VistaGen Therapeutics, Inc.
Clinical trials sponsored by VistaGen Therapeutics, Inc., explained in plain language.
A biopharmaceutical company developing therapies for central nervous system disorders.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
-
Nasal spray aims to calm social anxiety fast in public speaking situations
Symptom relief OngoingThis study tests an experimental nasal spray called fasedienol for quickly reducing anxiety during a public speaking challenge in adults with social anxiety disorder. About 238 participants will receive either the spray or a placebo and rate their distress levels. The goal is to …
Phase 3 • Sponsor: VistaGen Therapeutics, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 12:36 UTC
-
New nasal spray could tame stage fright in social anxiety
Symptom relief OngoingThis Phase 3 trial tests whether a nasal spray called fasedienol can quickly reduce anxiety during a public speaking challenge in adults with social anxiety disorder. About 238 participants will receive either the spray or a placebo before speaking. The study also looks at long-t…
Phase 3 • Sponsor: VistaGen Therapeutics, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 08:00 UTC